Here’s what I see across hundreds of patient histories as a PMDD psychiatrist Austin patients trust: a woman who functions at a high level for roughly three weeks of every month. Then, in the late luteal phase, the week or so before her period, the floor drops. Irritability with a violence that frightens her. Despair that feels chemical. Rejection sensitivity, rage, insomnia, cognitive fog. Then her period starts, and within days she is herself again.
By the time she reaches me, she has usually been told one of three things: that it’s PMS, that it’s bipolar disorder, or that it’s stress.
It is frequently none of those. It is premenstrual dysphoric disorder, and the mechanism matters.
The mechanism
Women with PMDD do not have abnormal hormone levels. This has been demonstrated repeatedly: their estradiol and progesterone curves look like everyone else’s. What differs is the brain’s response to normal hormonal change. Specifically, an altered central sensitivity to allopregnanolone, a progesterone metabolite that acts on GABA-A receptors, the brain’s primary calming system (Schmidt et al., NEJM; Eisenlohr-Moul; Hantsoo & Epperson).
In most women, allopregnanolone is calming. In PMDD, the receptor response is dysregulated. The same molecule produces agitation, depression, and irritability on a predictable monthly schedule.
This is why PMDD is classified as a depressive disorder in DSM-5, why it carries a documented elevation in suicide risk, and why “just manage your stress” is not a treatment plan. The problem is not the hormones. It is the receptor’s reading of them.
The ADHD finding that changes the differential
Recent research sharpened this picture considerably. A 2025 study in the British Journal of Psychiatry (Broughton, Agnew-Blais et al.) found that women with a clinical ADHD diagnosis were more than three times as likely to meet criteria for PMDD; women with high ADHD symptom loads, including the undiagnosed, were over four times as likely. Among women with ADHD plus anxiety or depression, the risk rose further still.
I read that against the structure of most psychiatric care. ADHD in women is already under-recognized; the inattentive presentation common in high-functioning women rarely looks like the textbook. PMDD is also under-recognized, particularly among women experiencing hormonal mood symptoms. A woman carrying both is typically diagnosed with neither. She is told she’s anxious, moody, or “doing too much,” while two interacting conditions go unmapped.
She is also the woman most likely to tell me her stimulant seems to stop working the week before her period. That observation is not in her head. Estradiol modulates dopamine signaling; when it falls in the late luteal phase, ADHD symptoms and medication response measurably shift.
Most psychiatrists evaluate these conditions separately, if at all. I treat the cycle as data.
What precise diagnosis requires
I can’t diagnose PMDD accurately in a single conversation, and I don’t try to. The gold standard is prospective daily symptom rating across at least two cycles, because retrospective memory reliably distorts timing, and timing is the entire diagnosis. My evaluation includes:
- Prospective cycle mapping using a daily symptom rating across at least two cycles, to confirm the symptoms are genuinely confined to the luteal phase
- Differential against bipolar II, the most consequential misdiagnosis in this population, in both directions
- ADHD assessment with attention to the inattentive, internalized presentation common in professional women
- Thyroid, iron, and metabolic screening for the biological amplifiers that worsen luteal symptoms
- Treatment architecture. The evidence supports several distinct strategies: continuous or luteal-phase SSRIs (which work within days in PMDD, through the allopregnanolone pathway, not the weeks-long mechanism of depression), cycle-stabilizing hormonal approaches, and in severe cases ovulation suppression. Which one I choose, and in what sequence, comes out of the evaluation, not out of what’s quickest to prescribe.
Medication and supplementation, together
Most PMDD care splits into two camps. Conventional psychiatry prescribes and stops there. Wellness culture supplements and refuses the prescription. Both are incomplete, and the evidence supports neither purity. I work in the middle, and I hold the whole plan to one standard: it has to be earning its place.
Several supplements have legitimate trial data in premenstrual disorders, and I treat them as treatment, not as decoration:
- Calcium has the strongest evidence base of any supplement in premenstrual symptoms, with randomized controlled trial support for reducing luteal mood and physical symptoms (Thys-Jacobs et al.). Calcium handling is itself cyclically regulated by estrogen, which is the mechanistic reason it matters here.
- Vitamin B6 has meta-analytic support for premenstrual mood symptoms at modest doses. It is also the supplement most often self-dosed into peripheral neuropathy, so I watch the ceiling as closely as the effect.
- Magnesium carries evidence for the affective and physical symptom cluster, with biological plausibility through its role in NMDA and GABA signaling.
- Vitamin D I correct when testing shows deficiency, because low vitamin D amplifies the luteal phenotype and observational data links deficiency to premenstrual mood symptoms. There is also an individual-variability layer I take seriously: polymorphisms in the vitamin D receptor (VDR) gene mean two women with identical blood levels can have different cellular vitamin D signaling. A woman with a VDR variant may need her status interpreted and corrected more aggressively than her serum number alone suggests. This is exactly the kind of biological detail a standard med-check never reaches, and it is why I test before I supplement. I correct iron on the same logic when ferritin is low.
- Chasteberry (Vitex agnus-castus) has randomized trial support in premenstrual syndrome and is one of the few botanicals I’ll discuss seriously, with the important caveat that it acts on dopamine and prolactin signaling, so I evaluate it alongside, never instead of, the psychiatric differential.
What this is not: a supplement protocol to download. Doses, combinations, and interactions (B6 ceilings, chasteberry alongside dopaminergic medications, calcium timing against thyroid medication) I determine within the evaluation, against your labs and your prescription list. Supplements are pharmacology. I give them pharmacological respect, in both directions.
Two non-supplement adjuncts earn a place on the same evidence-graded basis:
- Light therapy. Bright-light exposure has randomized controlled trial support in PMDD specifically, with a plausible mechanism through circadian and serotonergic pathways that are already disturbed in the luteal phase. It is low-risk, it pairs cleanly with medication, and for women whose luteal symptoms include the early-waking, low-light-season pattern, it can do real work.
- Yoga and structured mind-body practice. Trial evidence supports yoga for premenstrual symptom severity, and the mechanism is not mysterious: regulated breathing and parasympathetic activation push back on exactly the autonomic and GABAergic dysregulation that defines the luteal crash. I position it as adjunctive symptom regulation, not as a substitute for treating a DSM-5 depressive disorder. That distinction is the whole point.
The principle across all of it: medication is the evidence-anchored core, and I integrate everything else where it fits you, against your biology, not as a universal protocol. A combined plan is built for the individual. It is not a menu.
For many women the durable answer is layered: an SSRI strategy matched to her cycle, deficiencies corrected, and a small number of evidence-supported supplements doing real mechanistic work underneath. Not medication or supplementation. Architecture.
Who this is for
If you’ve tracked your own symptoms in an app for a year because no one else would look at the data, if you want the mechanism and not a metaphor, if you’d rather work with someone who treats your observations as evidence: I built this work for you.
If what you need is a same-week prescription with minimal assessment, that exists elsewhere, and you deserve a setting that matches what you’re looking for. I keep a deliberately limited roster so the evaluation can be exhaustive. That’s by design.
The practice
Dr. Lauren Williams is a board-certified PMDD psychiatrist Austin patients turn to when symptoms are complex and layered: PMDD with ADHD, anxiety with hormonal sensitivity, depression with a biological underside no one measured. Care is structured around comprehensive psychiatric and biological evaluation.
If the pattern in this article is your pattern, you may request a consultation. We’ll both find out if it’s a fit.
Frequently Asked Questions
What is the difference between PMS and PMDD?
PMS involves mild, manageable premenstrual symptoms. PMDD is a DSM-5 depressive disorder involving severe mood symptoms (despair, rage, rejection sensitivity, cognitive impairment) confined to the luteal phase, with functional impairment and elevated suicide risk. The distinction is severity, impairment, and timing confirmed by prospective tracking.
Are PMDD and ADHD related?
Yes. 2025 research found women with ADHD are three to four times more likely to meet PMDD criteria. Both involve sensitivity to hormonal modulation of brain signaling, and each makes the other harder to recognize.
Why do SSRIs work faster for PMDD than for depression?
In PMDD, SSRIs act rapidly on the synthesis of allopregnanolone, the progesterone metabolite driving symptoms. The effect is measurable within days, unlike the multi-week course typical in major depression. This is also why intermittent, luteal-phase-only dosing is an evidence-supported option.
Do supplements help PMDD?
Some have real evidence: calcium has randomized controlled trial support, vitamin B6 has meta-analytic support at modest doses, and magnesium and chasteberry carry trial data. They work best as part of a combined plan with lab-guided correction of deficiencies and, where indicated, medication. Doses and interactions matter, so they should be set within an evaluation rather than self-assembled.
Can PMDD be treated with supplements and lifestyle instead of medication?
For severe PMDD, a DSM-5 depressive disorder with elevated suicide risk, medication is the evidence-anchored core of treatment. That said, several adjuncts have legitimate trial data and are integrated alongside it: calcium, vitamin B6, magnesium, and chasteberry among supplements; light therapy and yoga among non-supplement approaches; and correction of vitamin D or iron deficiency where testing shows it, with attention to vitamin D receptor (VDR) variation. These are combined into an individualized plan, not offered as a replacement for psychiatric evaluation.
Who treats PMDD in Austin?
Dr. Lauren Williams evaluates and treats PMDD, including PMDD co-occurring with ADHD, anxiety, and depression, in adult women in Austin, Texas, through a comprehensive private-pay evaluation model.
